Report explores the specimen labeling standards recommended by the National Cancer Institute
MILWAUKEE, Wis. (October 28, 2014) – Brady (NYSE:BRC), a global leader in product and facility identification solutions, today released its “Labeling of Biological Specimens” whitepaper. The report provides the necessary technical and product-related information to be able to standardize labels used on various types of biological specimens collected by the National Cancer Institute (NCI) and their collaborators for NCI-directed studies.
“When it comes to research, testing and collaboration between labs, it’s essential to establish a standardized labeling method,” says Dana Ray, global market manager, lab and medical for Brady. “Our latest whitepaper provides valuable information on the exact label specifications, supplies and equipment needed to effectively label and store biological specimen at the different temperatures commonly used by the NCI. With a labeling standard in place, research and testing can be more productive and efficient.”
Brady’s whitepaper outlines the technical and product-related information that will help optimize sample identification according to the NCI standards. It includes label configurations of four common specimen vessels, preferences for size, readable information and 2D barcodes, and suggested tools for printing, data collection and software.
For a free copy of the report, visit BradyID.com/lab.
For more Information:
About Brady Corporation:
Brady Corporation (NYSE: BRC) is an international manufacturer and marketer of complete solutions that identify and protect premises, products and people. Its products include high-performance labels and signs, safety devices, printing systems and software, and precision die-cut materials. Founded in 1914, the company has millions of customers in electronics, telecommunications, manufacturing, electrical, construction, education, medical and a variety of other industries. Brady is headquartered in Milwaukee and employs 6,900 people at operations in the Americas, Europe and Asia/Pacific. Brady’s fiscal 2012 sales were approximately $1.3 billion. More information about Brady Corporation is available at www.bradycorp.com.
# # #